Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour first dose of tirzepatide is 2.5 mg — a starting point chosen deliberately to let your body adjust, not to produce immediate weight loss. Most people tolerate it well, though some mild nausea or digestive discomfort is common in the days that follow. Tirzepatide is a prescription-only medicine; a clinician reviews whether it is suitable for you before it is prescribed. Here is exactly what happens, step by step, from the moment you open the box to the morning after your first injection, so you know what is normal and what warrants a call to your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Take the Mounjaro KwikPen out of the fridge roughly 30 minutes before injecting. A cold pen is not dangerous, but room-temperature medicine tends to sting less going in. While it warms up, wash your hands thoroughly and, if you are using an alcohol swab, clean the chosen site and let it dry completely before the needle goes near it.
Choose one of three sites: abdomen (at least two finger-widths from the navel), front or outer thigh, or the back of the upper arm. The abdomen is the most common starting point, it is easy to pinch and reach. You can learn more about the full injection technique for your first Mounjaro dose if you want a detailed walkthrough of grip, angle and needle depth.
Pick a day and time you can stick to each week. Many people choose a Sunday evening or a weekday morning, whatever fits your routine. Consistency matters because tirzepatide builds up over successive weekly doses, and irregular timing can affect tolerability. Note it in your phone calendar the same way you would a standing appointment.
The NHS tirzepatide medicines page has a clear summary of injection technique alongside storage guidance, worth bookmarking before your first dose.
Remove the cap, press the pen firmly against the skin at a 90-degree angle, and hold the button down until you hear or feel two clicks) the first starts the injection, the second confirms the dose is complete. Keep the pen pressed against the skin for a full ten seconds after the second click before lifting it away. That pause matters: it gives the medicine time to disperse under the skin rather than leaking back out.
Most people feel very little. A brief sting or a slight pressure sensation at the site is normal. Occasionally a small raised area or mild redness appears at the injection site; this usually fades within an hour or two and is not a reason to stop treatment. If you notice significant swelling, warmth or a rash spreading beyond the site, contact your prescriber.
Once the pen is used, replace the outer cap and dispose of it in a sharps container immediately. Never recap with the needle uncovered.
The 2.5 mg tirzepatide dose page covers what this starting strength actually does in the body and why the schedule is built the way it is.
This is when most people notice whatever side effects they are going to have. Nausea is the most reported, usually arriving a few hours after the injection and peaking the next morning. Loose stools, indigestion, burping and a general feeling of fullness even when you have eaten very little are all part of the same pattern. They reflect tirzepatide slowing the rate at which your stomach empties, which is also part of how it reduces appetite over time.
Practical steps that help: eat smaller portions than usual that day, avoid high-fat or very rich food, stay well hydrated, and do not skip meals entirely even if your appetite has dropped sharply. If you want a detailed guide to what to expect from your Mounjaro first dose, including how to manage nausea and what counts as normal in those early hours, that page covers it thoroughly.
Fatigue and a mild headache can also appear after the first tirzepatide dose, likely linked to lower food intake and the body's adjustment to the medicine. Both typically pass without intervention.
If you experience severe, persistent stomach pain that radiates to your back (especially with vomiting) seek urgent medical attention. The MHRA flagged acute pancreatitis as a known, though infrequent, risk with GLP-1 medicines in its January 2026 Drug Safety Update; this is one symptom that should not be waited out. You can report any suspected side effects directly at the MHRA Yellow Card scheme.
After four weeks on 2.5 mg, your prescriber will typically move you up to the next strength. The schedule is designed to increase the dose gradually (giving your digestive system time to adapt at each level) before reaching the dose that does the main therapeutic work. The tirzepatide dosing schedule page explains the full titration pathway and what to expect at each step.
Some people do not move up immediately; if tolerability at 2.5 mg is still challenging at four weeks, staying longer on the starter dose is a legitimate clinical decision. That is a conversation for your prescriber, not something to adjust on your own. The Patient Information Leaflet that comes with your pen is the definitive reference for what to do if you miss a dose or need to delay an injection.
Understanding the cost of staying on treatment long-term is a reasonable question at this stage. The Mounjaro pricing page sets out what private treatment typically involves, including what an all-in price should cover.
The broader picture of what tirzepatide is and how it works as a dual GIP and GLP-1 receptor agonist is covered on the Mounjaro treatment page. And if you have already had your consultation and want to explore your options across all available weight-loss treatments, the weight-loss treatments overview is a useful starting point.
If you have not yet spoken to a prescriber, a free consultation with the nume clinical team is the right next step. A GPhC-registered prescriber reads your answers personally and, if tirzepatide is suitable, can have treatment on its way the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.